SV2009003328A - Marcacion radioactiva por fluoracion de aziridinas - Google Patents
Marcacion radioactiva por fluoracion de aziridinasInfo
- Publication number
- SV2009003328A SV2009003328A SV2009003328A SV2009003328A SV2009003328A SV 2009003328 A SV2009003328 A SV 2009003328A SV 2009003328 A SV2009003328 A SV 2009003328A SV 2009003328 A SV2009003328 A SV 2009003328A SV 2009003328 A SV2009003328 A SV 2009003328A
- Authority
- SV
- El Salvador
- Prior art keywords
- fluoration
- aziridines
- dialing
- radioactive
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C07D203/24—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS COMPUESTOS ADECUADOS PARA SER MARCADOS O YA MARCADOS RADIOACTIVAMENTE CON F, MÉTODOS PARA PREPARAR TALES COMPUESTOS Y USO DE LOS MISMOS PARA DIAGNÓSTICO POR IMÁGENES
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07090001A EP1944288A1 (en) | 2007-01-09 | 2007-01-09 | Radiolabelling via fluorination of aziridines |
EP07090079A EP1985624A3 (en) | 2007-04-23 | 2007-04-23 | Single step method of radiofluorination of biologically active compounds or biomolecules |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2009003328A true SV2009003328A (es) | 2009-12-14 |
Family
ID=38941926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2009003328A SV2009003328A (es) | 2007-01-09 | 2009-07-09 | Marcacion radioactiva por fluoracion de aziridinas |
Country Status (24)
Country | Link |
---|---|
US (1) | US20090022664A1 (es) |
EP (1) | EP2099747A1 (es) |
JP (1) | JP2010522140A (es) |
KR (1) | KR20090096716A (es) |
AR (1) | AR062856A1 (es) |
AU (1) | AU2007343454A1 (es) |
BR (1) | BRPI0720884A2 (es) |
CA (1) | CA2674408A1 (es) |
CL (1) | CL2007002673A1 (es) |
CO (1) | CO6220852A2 (es) |
CR (1) | CR10917A (es) |
DO (1) | DOP2009000173A (es) |
EC (1) | ECSP099505A (es) |
MA (1) | MA31175B1 (es) |
MX (1) | MX2009007395A (es) |
NO (1) | NO20092813L (es) |
PA (1) | PA8747801A1 (es) |
PE (1) | PE20081661A1 (es) |
RU (1) | RU2009130455A (es) |
SV (1) | SV2009003328A (es) |
TN (1) | TN2009000233A1 (es) |
TW (1) | TW200829275A (es) |
UY (1) | UY30594A1 (es) |
WO (1) | WO2008083729A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8784774B2 (en) | 2011-09-16 | 2014-07-22 | General Electric Company | Labeled molecular imaging agents and methods of use |
US9468692B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
US9468693B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
NL2014828B1 (en) * | 2015-05-20 | 2017-01-31 | Out And Out Chemistry S P R L | Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3954994A (en) * | 1968-10-03 | 1976-05-04 | Pfizer Inc. | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents |
JPS5810380B2 (ja) * | 1975-01-31 | 1983-02-25 | 三共株式会社 | ペプチドノ セイホウ |
US6015790A (en) * | 1997-10-06 | 2000-01-18 | Basf Aktiengesellschaft | Methods and compositions for treating rheumatoid arthritis |
EP2098514A1 (en) * | 1999-07-21 | 2009-09-09 | The Trustees Of The University Of Pennsylvania | Preparation of compounds useful for the detection of hypoxia |
SE9903998D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
US6894057B2 (en) * | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
WO2004014377A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
GB0222909D0 (en) * | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
CN1212307C (zh) * | 2003-07-23 | 2005-07-27 | 中国科学院上海有机化学研究所 | 一种合成β-氟胺化合物的方法 |
AU2005289881A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
CA2602146A1 (en) * | 2005-04-07 | 2006-10-19 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
-
2007
- 2007-09-07 AU AU2007343454A patent/AU2007343454A1/en not_active Abandoned
- 2007-09-07 MX MX2009007395A patent/MX2009007395A/es unknown
- 2007-09-07 WO PCT/EP2007/007968 patent/WO2008083729A1/en active Application Filing
- 2007-09-07 BR BRPI0720884-7A patent/BRPI0720884A2/pt not_active IP Right Cessation
- 2007-09-07 CA CA002674408A patent/CA2674408A1/en not_active Abandoned
- 2007-09-07 KR KR1020097014304A patent/KR20090096716A/ko not_active Application Discontinuation
- 2007-09-07 EP EP07802294A patent/EP2099747A1/en not_active Withdrawn
- 2007-09-07 JP JP2009545069A patent/JP2010522140A/ja active Pending
- 2007-09-07 US US11/851,786 patent/US20090022664A1/en not_active Abandoned
- 2007-09-07 RU RU2009130455/04A patent/RU2009130455A/ru not_active Application Discontinuation
- 2007-09-10 TW TW096133836A patent/TW200829275A/zh unknown
- 2007-09-14 CL CL200702673A patent/CL2007002673A1/es unknown
- 2007-09-14 UY UY30594A patent/UY30594A1/es not_active Application Discontinuation
- 2007-09-14 AR ARP070104087A patent/AR062856A1/es unknown
- 2007-09-14 PE PE2007001247A patent/PE20081661A1/es not_active Application Discontinuation
- 2007-09-14 PA PA20078747801A patent/PA8747801A1/es unknown
-
2009
- 2009-06-08 TN TNP2009000233A patent/TN2009000233A1/fr unknown
- 2009-07-08 DO DO2009000173A patent/DOP2009000173A/es unknown
- 2009-07-09 EC EC2009009505A patent/ECSP099505A/es unknown
- 2009-07-09 CR CR10917A patent/CR10917A/es unknown
- 2009-07-09 SV SV2009003328A patent/SV2009003328A/es not_active Application Discontinuation
- 2009-07-09 CO CO09071219A patent/CO6220852A2/es not_active Application Discontinuation
- 2009-08-06 MA MA32154A patent/MA31175B1/fr unknown
- 2009-08-07 NO NO20092813A patent/NO20092813L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20092813L (no) | 2009-09-22 |
TW200829275A (en) | 2008-07-16 |
ECSP099505A (es) | 2009-08-28 |
MX2009007395A (es) | 2009-07-17 |
UY30594A1 (es) | 2008-09-02 |
KR20090096716A (ko) | 2009-09-14 |
AU2007343454A1 (en) | 2008-07-17 |
RU2009130455A (ru) | 2011-02-20 |
AR062856A1 (es) | 2008-12-10 |
MA31175B1 (fr) | 2010-02-01 |
PE20081661A1 (es) | 2009-01-18 |
TN2009000233A1 (en) | 2010-10-18 |
WO2008083729A1 (en) | 2008-07-17 |
JP2010522140A (ja) | 2010-07-01 |
BRPI0720884A2 (pt) | 2014-03-25 |
CL2007002673A1 (es) | 2008-07-18 |
US20090022664A1 (en) | 2009-01-22 |
CA2674408A1 (en) | 2008-07-17 |
EP2099747A1 (en) | 2009-09-16 |
DOP2009000173A (es) | 2010-10-31 |
CO6220852A2 (es) | 2010-11-19 |
CR10917A (es) | 2009-08-27 |
PA8747801A1 (es) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2582284T3 (es) | Composición que comprende microbiota intestinal humana anaeróbicamente cultivada | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
PA8747701A1 (es) | Métodos de marcación con flúor radioactivo | |
CL2016001287A1 (es) | Benzamidas sustituidas y procedimiento para su uso | |
ECSP12012221A (es) | Anticuerpos anti-cd40 | |
CO7141405A2 (es) | Uso de pro-fungicidas de uk-2a para el control de la sigatoka negra | |
CR20140180A (es) | Inhibidores macrocíclicos de serina proteasas de hepatitis c | |
ECSP10010722A (es) | Compuestos orgánicos | |
UY33872A (es) | Uso de análogos de glucagón acilados | |
CL2010001530A1 (es) | Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios. | |
CR11672A (es) | Compuestos plaguicidas de arilo de anillo condensado | |
BRPI0910368A2 (pt) | "uso de um ou mais intensificadores escolhidos entre biointensificadores e fotointensificadores, composição para o uso de um ou mais intensificadores escolhidos entre biointensificadores e fotointensificadores e colírio para uso de um ou mais intensificadores escolhidos entre biointensificadores e fotointensificadores" | |
CL2012000429A1 (es) | Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias. | |
ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
ECSP13012519A (es) | Compuestos sustituidos de benzamida | |
BR112015023642A2 (pt) | uso de perfusão de fígado descelularizado para permitir recelularização de célula | |
BR112014009471A2 (pt) | compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
ES2620754T3 (es) | Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores | |
CR20110497A (es) | Nuevos anticuerpos anti-alfa5beta1 y sus usos | |
CO7020909A2 (es) | Compuesto tricíclicos, composiciones que los comprenden y uso de los mismos | |
BR112014029642A2 (pt) | composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
SV2009003328A (es) | Marcacion radioactiva por fluoracion de aziridinas | |
PA8747601A1 (es) | Marcaciòn con fluor radioactivo | |
PA8796801A1 (es) | Sintesis quiral de diazepinoquinolinas | |
CO6400197A2 (es) | Composición de compuestos fenolicos que contienen palma aceitera para el suministro de efectos neuroprotectores y mejora cognitiva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |